May 1, 2019 - Experimental Treatment Could Be "Game-Changing" For Inherited ALS

The results of a Phase 2 trial using a drug strategy pioneered by our director, Richard Smith M.D., in collaboration with Ionis Pharmaceuticals and the University of California, San Diego has been reported to demonstrate promising results in a Biogen-sponsored treatment trial. Click here for more information.

January 12, 2019 – California 9th ALS Research Summit

Dr. Richard Smith spoke during the 'Meet the Experts' session at the California 9th ALS Research Summit held at UC Irvine. Click here to see a recording of his presentation.

December 7-9, 2018 – 29th International ALS/MND Symposium

At the 29th International ALS/MND Symposium in Glasgow, Scotland, Dr. Smith presented on "The Computer Assessment of Speech in a Successful ALS Treatment Trial". The abstract is can be found here.